Spatial Distribution of Ciprofloxacin Resistance in <em>C. jejuni</em> Isolates from Human Cases (IMAGE)

European Centre for Disease Prevention and Control (ECDC)

Spatial Distribution of Ciprofloxacin Resistance in <em>C. jejuni</em> Isolates from Human Cases

Caption

The highest proportion of resistance was reported by countries in southern and eastern Europe and in the Baltic, whereas countries in northern and central parts of Europe reported lower resistance levels.

When the level of resistance to an antibiotic (e.g. Ciprofloxacin) in Campylobacter from humans is above 70 percent, it can no longer be regarded as effective treatment.

Credit

ECDC/EFSA, 2019

Usage Restrictions

Use authorised provided the source is acknowledged

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.